Physician profile
Amir Lavaf
NPI 1508024852
$411,490.85
in general payments reported to CMS, 2019-2025
51 companies · $14K in 2025
The $14K reported for 2025 was more than what 97% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $48K · 2021: $53K · 2022: $110K · 2023: $96K · 2024: $54K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Consulting Fee: $32K · Honoraria: $24K · Travel and Lodging: $22K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $21K · Food and Beverage: $9,487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $55,125.00 |
| Consulting Fee | $31,770.00 |
| Honoraria | $24,132.46 |
| Travel and Lodging | $22,290.01 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $21,400.00 |
| Food and Beverage | $9,486.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $107,485.89 | 2021-2025 | Osteocool Rf Ablation System, Synchromedii, Intellis Adaptivestim |
| Novocure INC. | $106,985.76 | 2019-2025 | Optune, Optune Lua (Novottf-200t) |
| Novocure Gmbh | $80,250.00 | 2021-2022 | |
| Telix Pharmaceuticals | $59,321.89 | 2023-2024 | Illuccix |
| Medtronic USA, INC. | $46,662.56 | 2019-2020 | |
| Emd Serono, INC. | $3,621.23 | 2023-2025 | Bavencio |
| Astrazeneca Pharmaceuticals LP | $1,332.23 | 2019-2025 | Imfinzi, Calquence |
| Cardinal Health 414 LLC | $600.00 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $525.85 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $509.27 | 2024-2025 | Libtayo |
| Karyopharm Therapeutics INC. | $448.87 | 2021-2025 | Xpovio |
| Genzyme Corporation | $379.67 | 2021-2024 | |
| Icotec Medical INC. | $348.71 | 2023-2024 | Icotec Blackarmor Spine System, Vader Pedicle System |
| Merck Sharp & Dohme LLC | $297.56 | 2019-2020 | |
| Gt Medical Technologies, INC | $245.25 | 2023-2025 | Gammatile, Gammatile |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $242.60 | 2022-2025 | Verzenio, Jaypirca, Retevmo |
| Novartis Pharmaceuticals Corporation | $203.25 | 2019-2025 | |
| Amgen INC. | $175.93 | 2019-2023 | Xgeva, Nplate |
| Janssen Biotech, INC. | $173.70 | 2022-2025 | Talvey, Darzalex, Carvykti |
| Intuitive Surgical, INC. | $153.09 | 2024 | |
| Ethicon INC. | $147.01 | 2022 | |
| Galvanize Therapeutics, INC | $135.52 | 2025 | Aliya System |
| Daiichi Sankyo INC. | $102.56 | 2021 | |
| Springworks Therapeutics, INC. | $91.26 | 2024-2025 | Ogsiveo |
| Rigel Pharmaceuticals, INC. | $86.89 | 2022-2024 | Rezlidhia, Tavalisse |
| Pfizer INC. | $64.16 | 2021-2024 | |
| Incyte Corporation | $63.24 | 2022-2025 | Jakafi |
| Astellas Pharma US INC | $55.79 | 2024-2025 | Padcev, Xtandi |
| Sobi, INC | $54.49 | 2022-2023 | |
| Siemens Medical Solutions USA, INC. | $52.81 | 2020-2025 | System Somatom Confidence, Somatom Go.Top |
| Erbe USA INC | $50.00 | 2024 | |
| Eisai INC. | $48.96 | 2023-2024 | |
| Ge Healthcare | $48.38 | 2025 | |
| Array Biopharma INC | $48.22 | 2019-2024 | Lorbrena |
| Deciphera Pharmaceuticals INC. | $43.87 | 2025 | Qinlock, Tgct, Romvimza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.20 | 2019-2020 | |
| Seagen INC. | $43.05 | 2022 | |
| Kyowa Kirin, INC. | $42.13 | 2023 | Poteligeo |
| Blueprint Medicines Corporation | $40.66 | 2022-2024 | Ayvakit |
| Monteris Medical Corporation | $35.24 | 2019-2020 | |
| Pharmaessentia USA Corporation | $33.22 | 2025 | Besremi |
| Blue Earth Diagnostics | $28.74 | 2023 | |
| Alexion Pharmaceuticals, INC. | $26.56 | 2021 | |
| Abbvie INC. | $22.67 | 2024 | |
| Jazz Pharmaceuticals INC. | $20.40 | 2025 | |
| Foundation Medicine, INC. | $20.04 | 2019 | |
| Celgene Corporation | $18.90 | 2019 | |
| Puma Biotechnology, INC. | $16.65 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.72 | 2023 | |
| Helsinn Therapeutics (U.S.), INC. | $15.32 | 2019 | |
| Servier Pharmaceuticals LLC | $11.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Lavaf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.